US Bancorp’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-15
Closed -$292 4082
2023
Q2
$292 Sell
15
-610
-98% -$11.9K ﹤0.01% 3873
2023
Q1
$17.7K Sell
625
-171
-21% -$4.85K ﹤0.01% 3039
2022
Q4
$23.3K Buy
796
+278
+54% +$8.13K ﹤0.01% 2910
2022
Q3
$14K Sell
518
-361
-41% -$9.76K ﹤0.01% 3227
2022
Q2
$39K Buy
879
+302
+52% +$13.4K ﹤0.01% 2713
2022
Q1
$29K Sell
577
-7,160
-93% -$360K ﹤0.01% 2875
2021
Q4
$394K Sell
7,737
-81
-1% -$4.13K ﹤0.01% 1649
2021
Q3
$437K Sell
7,818
-500
-6% -$27.9K ﹤0.01% 1587
2021
Q2
$356K Sell
8,318
-313
-4% -$13.4K ﹤0.01% 1718
2021
Q1
$361K Buy
8,631
+44
+0.5% +$1.84K ﹤0.01% 1660
2020
Q4
$399K Sell
8,587
-159
-2% -$7.39K ﹤0.01% 1560
2020
Q3
$371K Sell
8,746
-731
-8% -$31K ﹤0.01% 1488
2020
Q2
$454K Sell
9,477
-842
-8% -$40.3K ﹤0.01% 1346
2020
Q1
$475K Buy
10,319
+189
+2% +$8.7K ﹤0.01% 1223
2019
Q4
$608K Buy
10,130
+1,000
+11% +$60K ﹤0.01% 1269
2019
Q3
$517K Buy
9,130
+861
+10% +$48.8K ﹤0.01% 1353
2019
Q2
$460K Buy
8,269
+427
+5% +$23.8K ﹤0.01% 1444
2019
Q1
$396K Buy
7,842
+543
+7% +$27.4K ﹤0.01% 1495
2018
Q4
$295K Buy
7,299
+4,087
+127% +$165K ﹤0.01% 1581
2018
Q3
$223K Buy
3,212
+445
+16% +$30.9K ﹤0.01% 1812
2018
Q2
$209K Buy
2,767
+1,819
+192% +$137K ﹤0.01% 1849
2018
Q1
$50K Hold
948
﹤0.01% 2624
2017
Q4
$51K Hold
948
﹤0.01% 2592
2017
Q3
$57K Sell
948
-61
-6% -$3.67K ﹤0.01% 2515
2017
Q2
$80K Hold
1,009
﹤0.01% 2309
2017
Q1
$84K Buy
1,009
+61
+6% +$5.08K ﹤0.01% 2236
2016
Q4
$75K Hold
948
﹤0.01% 2251
2016
Q3
$66K Buy
948
+85
+10% +$5.92K ﹤0.01% 2295
2016
Q2
$33K Hold
863
﹤0.01% 2607
2016
Q1
$35K Buy
+863
New +$35K ﹤0.01% 2545